Literature DB >> 22648536

Integration of the circadian and stress systems: influence of neuropeptides and implications for alcohol consumption.

Cybele C P Wong1, Gunter Schumann.   

Abstract

Disruptions in circadian rhythm and stress reactivity are associated with risks of developing neuropsychiatric disorders. The circadian system is organised in a hierarchical manner, whereby the master clock is located at the suprachiasmatic nucleus, a highly conserved brain region that coordinates the oscillations of peripheral clocks. Exposure to psychological stress leads to activation of the hypothalamic-pituitary-adrenal axis. There is growing evidence supporting the interactions between the circadian and stress systems. Anatomically, the circadian and stress signals converge at the paraventricular nucleus (PVN) in the hypothalamus. Genes that are involved in the operation of the circadian and stress systems, including Clock, Period and CRH are expressed in the PVN. In addition, several neuropeptides, including arginin-vasopressin, vasoactive intestinal polypeptide, pituitary adenylate cyclase-activating polypeptide and the neurotransmitter gamma-aminobutyric acid, are present in the PVN. In this review, we will discuss the interaction of circadian genes and stress-response genes at the molecular, neurotransmission and behavioural levels. We will place particular emphasis on the role of neuropeptides in mediating this interaction.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22648536     DOI: 10.1007/s00702-012-0829-4

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  89 in total

1.  Targeted disruption of the mPer3 gene: subtle effects on circadian clock function.

Authors:  L P Shearman; X Jin; C Lee; S M Reppert; D R Weaver
Journal:  Mol Cell Biol       Date:  2000-09       Impact factor: 4.272

2.  Voltage-gated calcium channels play crucial roles in the glutamate-induced phase shifts of the rat suprachiasmatic circadian clock.

Authors:  Do Young Kim; Hee Joo Choi; Jeong Sook Kim; Yoon Sik Kim; Do Ung Jeong; Hyung Cheul Shin; Mi Jin Kim; Hee-Chul Han; Seung Kil Hong; Yang In Kim
Journal:  Eur J Neurosci       Date:  2005-03       Impact factor: 3.386

Review 3.  Minireview: Circadian control of metabolism by the suprachiasmatic nuclei.

Authors:  Andries Kalsbeek; Felix Kreier; Eric Fliers; Hans P Sauerwein; Johannes A Romijn; Ruud M Buijs
Journal:  Endocrinology       Date:  2007-09-27       Impact factor: 4.736

4.  Effects of intravenously infused pituitary adenylate cyclase-activating polypeptide on adenohypophyseal Hormone secretion in normal men.

Authors:  P Chiodera; R Volpi; L Capretti; G Caffarri; M G Magotti; V Coiro
Journal:  Neuroendocrinology       Date:  1996-09       Impact factor: 4.914

5.  In vitro entrainment of the circadian rhythm of vasopressin-releasing cells in suprachiasmatic nucleus by vasoactive intestinal polypeptide.

Authors:  K Watanabe; J Vanecek; S Yamaoka
Journal:  Brain Res       Date:  2000-09-22       Impact factor: 3.252

6.  Vasopressin-deficient suprachiasmatic nucleus grafts re-instate circadian rhythmicity in suprachiasmatic nucleus-lesioned arrhythmic rats.

Authors:  G J Boer; K E van Esseveldt; B A van der Geest; H Duindam; W J Rietveld
Journal:  Neuroscience       Date:  1999-03       Impact factor: 3.590

7.  Colocalization of VIP with AVP in neurons of the human paraventricular, supraoptic and suprachiasmatic nucleus.

Authors:  H J Romijn; J F van Uum; J Emmering; V Goncharuk; R M Buijs
Journal:  Brain Res       Date:  1999-06-19       Impact factor: 3.252

8.  The central and basolateral nuclei of the amygdala exhibit opposite diurnal rhythms of expression of the clock protein Period2.

Authors:  Elaine Waddington Lamont; Barry Robinson; Jane Stewart; Shimon Amir
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-03       Impact factor: 11.205

9.  Role of mouse cryptochrome blue-light photoreceptor in circadian photoresponses.

Authors:  R J Thresher; M H Vitaterna; Y Miyamoto; A Kazantsev; D S Hsu; C Petit; C P Selby; L Dawut; O Smithies; J S Takahashi; A Sancar
Journal:  Science       Date:  1998-11-20       Impact factor: 47.728

10.  Vasoactive intestinal peptide is critical for circadian regulation of glucocorticoids.

Authors:  Dawn H Loh; Catalina Abad; Christopher S Colwell; James A Waschek
Journal:  Neuroendocrinology       Date:  2008-06-19       Impact factor: 4.914

View more
  6 in total

Review 1.  Preclinical evidence implicating corticotropin-releasing factor signaling in ethanol consumption and neuroadaptation.

Authors:  T J Phillips; C Reed; R Pastor
Journal:  Genes Brain Behav       Date:  2015-01       Impact factor: 3.449

Review 2.  Clock genes × stress × reward interactions in alcohol and substance use disorders.

Authors:  Stéphanie Perreau-Lenz; Rainer Spanagel
Journal:  Alcohol       Date:  2015-04-24       Impact factor: 2.405

Review 3.  Genetics and epigenetics of circadian rhythms and their potential roles in neuropsychiatric disorders.

Authors:  Chunyu Liu; Michael Chung
Journal:  Neurosci Bull       Date:  2015-02-06       Impact factor: 5.203

4.  Glucocorticoids and Stress-Induced Changes in the Expression of PERIOD1 in the Rat Forebrain.

Authors:  Sherin Al-Safadi; Marie Branchaud; Spencer Rutherford; Shimon Amir
Journal:  PLoS One       Date:  2015-06-15       Impact factor: 3.240

5.  Stress-induced changes in the expression of the clock protein PERIOD1 in the rat limbic forebrain and hypothalamus: role of stress type, time of day, and predictability.

Authors:  Sherin Al-Safadi; Aya Al-Safadi; Marie Branchaud; Spencer Rutherford; Arun Dayanandan; Barry Robinson; Shimon Amir
Journal:  PLoS One       Date:  2014-10-22       Impact factor: 3.240

Review 6.  The Circadian Molecular Machinery in CNS Cells: A Fine Tuner of Neuronal and Glial Activity With Space/Time Resolution.

Authors:  Francesca Fagiani; Eva Baronchelli; Anna Pittaluga; Edoardo Pedrini; Chiara Scacchi; Stefano Govoni; Cristina Lanni
Journal:  Front Mol Neurosci       Date:  2022-07-01       Impact factor: 6.261

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.